tiprankstipranks
Advertisement
Advertisement

Hankyu Hanshin REIT Completes Osaka Pharmacy Site Acquisition After New Appraisal

Story Highlights
  • Hankyu Hanshin REIT completed a 1.1 billion yen Osaka pharmacy site acquisition.
  • A new 1.15 billion yen appraisal under forward-commitment rules boosts valuation transparency.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Hankyu Hanshin REIT Completes Osaka Pharmacy Site Acquisition After New Appraisal

Claim 55% Off TipRanks

An update from Hankyu Hanshin REIT, Inc. ( (JP:8977) ) is now available.

Hankyu Hanshin REIT, Inc. has completed the acquisition of the site for the tentatively named Sugi Pharmacy Daito Goryo Store in Daito City, Osaka Prefecture for 1.1 billion yen, excluding taxes and related costs. The deal, originally announced in October 2025 with a later change to the acquisition date, reinforces the REIT’s strategy of expanding its domestic property portfolio.

Because the purchase agreement was structured as a forward commitment, the asset manager obtained a fresh appraisal as of November 30, 2025, valuing the property at 1.15 billion yen based on income approaches. The updated appraisal, carried out by Daiwa Real Estate Appraisal, provides investors with transparency on the asset’s valuation and underscores the REIT’s adherence to its internal rules on forward commitments and disclosure.

More about Hankyu Hanshin REIT, Inc.

Hankyu Hanshin REIT, Inc. is a Japanese real estate investment trust focused on acquiring and managing income-producing domestic properties. Through its asset management company, Hankyu Hanshin REIT Asset Management, Inc., it invests primarily in real estate assets in Japan, aiming to generate stable returns for unitholders in the domestic REIT market.

Average Trading Volume: 1,748

Technical Sentiment Signal: Buy

Current Market Cap: Yen104.5B

Learn more about 8977 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1